Niamh O'Reilly

Niamh O'Reilly currently serves as Associate Director - Clinical Regulatory Scientist in Global Regulatory Affairs for the Americas at Eli Lilly and Company, a position held since December 2024. Prior to this role, Niamh worked as a Senior Regulatory Affairs Consultant at Parexel from September 2022 to December 2024 and as a Senior Regulatory Affairs Specialist at ICON plc from June 2021 to September 2022. Niamh's earlier experience includes serving as a Scientific Officer in Clinical Assessment at the Health Products Regulatory Authority (HPRA) from August 2020 to June 2021, where responsibilities included Clinical Assessment of Variations and Bioanalytical Methods. Niamh began a career in medical communications as a Medical Communications Specialist and Scientific Writer at CRC Australia from April 2017 to September 2019. Academic achievements include a PhD in Biology, with a focus on Immunology and Rosacea from Maynooth University, alongside an Advanced Diploma in Project Management from Dublin Business School.